Log in to save to my catalogue

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellula...

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellula...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7ffc53bb2d54631a09725a7151575b4

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

About this item

Full title

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2018-06, Vol.18 (1), p.633-633, Article 633

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as to whether hepatic arterial infusion chemotherapy (HAIC) or sorafenib is superior. We performed a prospective, open-label, non-comparative phase II study to assess survival with HAIC or HAIC converted to sorafenib.
Fifty-five patients were prospectively enrolled. Pa...

Alternative Titles

Full title

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b7ffc53bb2d54631a09725a7151575b4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7ffc53bb2d54631a09725a7151575b4

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-018-4519-y

How to access this item